FRESHAIR4Life: Building the Case for Action

NCT ID: NCT06074939

Last Updated: 2023-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1750 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-31

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to understand the burden and determinants of tobacco use and air pollution (AP) exposure among mid- to late adolescents in Greece, the Kyrgyz Republic, Pakistan, Romania, and Uganda. This context-specific knowledge will be crucial for selecting, adapting, and implementing preventive interventions in the next phase of the project.

The main questions the investigators aim to answer are:

* What is the perceived burden of tobacco use and AP exposure among adolescents?
* What are the contextual drivers and behavioral determinants contributing to (prevention of) these risk factors?
* How do the dynamics between stakeholders influence prevention efforts?

In this study, data will be collected through interviews, focus group discussions, photovoice, document analysis, observations, personal exposure monitoring, and questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use Pollution; Exposure Non-communicable Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescents: mid- to late-adolescents (14 to 21 years) within the target population;
* Family members: relatives in the first or second degree of (not necessarily participating) adolescents;
* Providers: any relevant stakeholder that is connected to adolescents through profession (e.g. school teacher, youth worker) and/or providers of (public) healthcare;
* Stakeholders: any relevant stakeholder with either a specific expertise, in-depth knowledge or overall overview on the subject, and in direct contact with the community (e.g. community member/leader, policy maker). Due to the community- and individual-level focus of this research, individuals associated with the tobacco industry are deliberately not included as stakeholders.

Exclusion Criteria

\- People living outside the target area or not in direct contact with the target population.
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University

OTHER

Sponsor Role collaborator

University of York

OTHER

Sponsor Role collaborator

University of Edinburgh

OTHER

Sponsor Role collaborator

The Initiative

UNKNOWN

Sponsor Role collaborator

Lungs Europe

UNKNOWN

Sponsor Role collaborator

International Primary Care Respiratory Group

UNKNOWN

Sponsor Role collaborator

University of Groningen

OTHER

Sponsor Role collaborator

University of Crete

OTHER

Sponsor Role collaborator

Ministry of Health, Kyrgyzstan

OTHER_GOV

Sponsor Role collaborator

Romanian Center for Studies in Family Medicine

UNKNOWN

Sponsor Role collaborator

Makerere University

OTHER

Sponsor Role collaborator

Leiden University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rianne MJJ van der Kleij, PhD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rianne MJJ van der Kleij, PhD

Role: PRINCIPAL_INVESTIGATOR

Leiden University Medical Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rianne MJJ van der Kleij, PhD

Role: CONTACT

+31622642623

Charlotte M Hoffman, MD

Role: CONTACT

+31638955206

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

101095461

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

10063681; 10060974; 1006440

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

23-3075

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Topography Study 2018
NCT03498053 COMPLETED NA